NMR studies of p7 protein from hepatitis C virus

被引:47
作者
Cook, Gabriel A. [1 ]
Opella, Stanley J. [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
来源
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS | 2010年 / 39卷 / 07期
关键词
Hepatitis C virus; p7; Solid-state NMR; Bicelles; SOLID-STATE NMR; TRANS-MEMBRANE DOMAIN; ION-CHANNEL; E2-NS2; REGION; DRUG DESIGN; SPECTROSCOPY; RIBAVIRIN; FIELD; COMBINATION; RESONANCE;
D O I
10.1007/s00249-009-0533-y
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The p7 protein of hepatitis C virus (HCV) plays an important role in the viral lifecycle. Like other members of the viroporin family of small membrane proteins, the amino acid sequence of p7 is largely conserved over the entire range of genotypes, and it forms ion channels that can be blocked by a number of established channel-blocking compounds. Its characteristics as a membrane protein make it difficult to study by most structural techniques, since it requires the presence of lipids to fold and function properly. Purified p7 can be incorporated into phospholipid bilayers and micelles. Initial solid-state nuclear magnetic resonance (NMR) studies of p7 in 14-O-PC/6-O-PC bicelles indicate that the protein contains helical segments that are tilted approximately 10A degrees and 25A degrees relative to the bilayer normal. A truncated construct corresponding to the second transmembrane domain of p7 is shown to have properties similar to those of the full-length protein, and was used to determine that the helix segment tilted at 10A degrees is in the C-terminal portion of the protein. The addition of the channel blocker amantadine to the full-length protein resulted in selective chemical shift changes, demonstrating that NMR has a potential role in the development of drugs targeted to p7.
引用
收藏
页码:1097 / 1104
页数:8
相关论文
共 42 条
[1]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[2]   Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].
Davis, GL ;
Esteban-Mur, R ;
Rustgi, V ;
Hoefs, J ;
Gordon, SC ;
Trepo, C ;
Shiffman, ML ;
Zeuzem, S ;
Craxi, A ;
Ling, MH ;
Albrecht, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499
[3]   Bicelle samples for solid-state NMR of membrane proteins [J].
De Angelis, Anna A. ;
Opella, Stanley J. .
NATURE PROTOCOLS, 2007, 2 (10) :2332-2338
[4]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[5]   RIBAVIRIN AS THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DIBISCEGLIE, AM ;
CONJEEVARAM, HS ;
FRIED, MW ;
SALLIE, R ;
PARK, Y ;
YURDAYDIN, C ;
SWAIN, M ;
KLEINER, DE ;
MAHANEY, K ;
HOOFNAGLE, JH ;
WRIGHT, D .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (12) :897-&
[6]   An improved broadband decoupling sequence for liquid crystals and solids [J].
Fung, BM ;
Khitrin, AK ;
Ermolaev, K .
JOURNAL OF MAGNETIC RESONANCE, 2000, 142 (01) :97-101
[7]   Viroporins [J].
Gonzalez, ME ;
Carrasco, L .
FEBS LETTERS, 2003, 552 (01) :28-34
[8]   The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine [J].
Griffin, SDC ;
Beales, LP ;
Clarke, DS ;
Worsfold, O ;
Evans, SD ;
Jaeger, J ;
Harris, MPG ;
Rowlands, DJ .
FEBS LETTERS, 2003, 535 (1-3) :34-38
[9]   Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose [J].
Hadziyannis, SJ ;
Sette, H ;
Morgan, TR ;
Balan, V ;
Diago, M ;
Marcellin, P ;
Ramadori, G ;
Bodenheimer, H ;
Bernstein, D ;
Rizzetto, M ;
Zeuzem, S ;
Pockros, PJ ;
Lin, A ;
Ackrill, AM .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) :346-355
[10]   Drug design - Discovering high-affinity ligands for proteins [J].
Hajduk, PJ ;
Meadows, RP ;
Fesik, SW .
SCIENCE, 1997, 278 (5337) :497-&